Author: OurCrowd

[ZutaCore in PR Newswire] ZutaCore and Munters Join Forces to Deliver a Waterless Data Center Architecture for AI Factories

Sep 17, 2024 |

SAN JOSE, Calif., Sept. 17, 2024 /PRNewswire/ — ZutaCore®, a leading provider of direct-to-chip, waterless liquid cooling solutions, and Munters, a global leader in energy-efficient air treatment and climate solutions, today announced the integration of their two platforms to provide a two-phase, waterless liquid cooling solution to sustainably cool AI factories faced with massive power densities driven by AI accelerators. Read...

Read More

[The Bouqs in Women.com] Here’s What Went Down With The Bouqs Company After Shark Tank

Sep 16, 2024 |

Here’s What Went Down With The Bouqs Company After Shark Tank In 2014, John Tabis showed up on season 5 of “Shark Tank” with flowers, pitching his business The Bouqs. Tabis had an epic idea to turn the flower business on its head. His business philosophy around flower delivery was straightforward: The product that customers receive should match the photo online. While that sounds pretty basic, it turns out it’s not that common when ordering flowers from standard online retailers. Not only that, Tabis promised that there wouldn’t be any surprise handling fees at the final stage of checkout. The only problem was that the sharks couldn’t wrap their toothy jaws around his innovative plan. Nevertheless, Tabis and The Bouqs have gone on to thrive more than almost any other business to grace the “Shark Tank” stage. Read more...

Read More

[Sequentify in PR Newswire] Sheba Medical Center to Utilize Sequentify’s InfiniSeq™ Panel in Study to Detect Clonal Hematopoiesis in Cancer Patients

Sep 16, 2024 |

The Hematology Laboratory, Molecular Hematology Unit, at Sheba Medical Center, Israel’s largest medical center, is conducting a joint study utilizing Sequentify’s InfiniSeq™ Myeloid Malignancies Panel. This study involves leading clinicians from the Cancer Center Institute, Maccabi Healthcare Services, and Sheba Cancer Research Center, focusing on identifying Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients previously diagnosed with solid tumors. The results from this study aim to advance personalized medicine in oncology, potentially influencing future patient care protocols. Read more...

Read More